imirestat has been researched along with Diabetes Mellitus, Type 1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blessing, K; Kador, PF; Makita, J; Randazzo, J; Zhang, P | 1 |
Averbuch, M; Brazzell, RK; Dobbs, RE; Liao, JC; Weintraub, M | 1 |
1 trial(s) available for imirestat and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Red blood cell sorbitol lowering effects and tolerance of single doses of AL 1576 (HOE 843) in diabetic patients.
Topics: Adolescent; Adult; Aldehyde Reductase; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Double-Blind Method; Erythrocytes; Female; Fluorenes; Humans; Hydantoins; Hypoglycemic Agents; Male; Middle Aged; Random Allocation; Sorbitol; Sugar Alcohol Dehydrogenases | 1988 |
1 other study(ies) available for imirestat and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Orally active multi-functional antioxidants delay cataract formation in streptozotocin (type 1) diabetic and gamma-irradiated rats.
Topics: Administration, Oral; Animals; Antioxidants; Body Weight; Cataract; Diabetes Mellitus, Type 1; Disease Progression; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Fluorenes; Gamma Rays; Heat-Shock Proteins; Humans; Hydantoins; Hyperglycemia; Lens Capsule, Crystalline; Pigmentation; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Streptozocin; Stress, Physiological | 2011 |